A review of melasma, part 1: Etiopathogenic factors, clinical and histopathologic evaluations

Cosmetic Dermatology

Volumn 19, Issue 11, 2006, Pages 683-687

  Machado Pinto, Jackson ^a   Borges, Maria De Fátima Melo ^a   Magalhães, Geraldo Magela ^a  

^a Santa Casa de Misericordia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BETA INTERMEDIN; BISMUTH; COPPER; COSMETIC; DOPA; ESTROGEN; GOLD; HYDANTOIN DERIVATIVE; INTERMEDIN; IRON; IRRITANT AGENT; MELANIN; MEPACRINE; MONOPHENOL MONOOXYGENASE; ORAL CONTRACEPTIVE AGENT; PHOTOSENSITIZING AGENT; PROGESTERONE; SILVER; STEROID;

ADDISON DISEASE; CHLOASMA; CLINICAL ASSESSMENT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HEREDITY; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; MASTOCYTOSIS; PATHOGENESIS; PHOTOSENSITIVITY DISORDER; POIKILODERMA; PREGNANCY; REVIEW; RISK FACTOR; SOLAR RADIATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

EID: 33846952852     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Newcomer VD, Lindberg MC, Sternberg TH. A melanosis of the face ("chloasma"). Arch Dermatol. 1961;83:284-299.
2. Vazquez M, Maldonado H, Benmaman C, et al. Melasma in men. A clinical and histologic study. Int J Dermatol. 1988;27:25-27.
3. Montemarano AD. Melasma. Available at: http://www.emedicine.com/derm/ topic260.htm. Accessed September 5, 2006.
4. Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4:698-710.
5. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-1457.
6. Halder RN, Grimes PE, McLaurin CI, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32:388-390.
7. Pathak MA, Riley FC, Fitzpatrick TB. Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J Invest Dermatol. 1962;39:435-443.
8. Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37:429-431.
9. Grando SA. Physiology of endocrine skin interrelations. J Am Acad Dermatol. 1993;28:981-992.
10. Perez M, Sanchez JL, Aguilo F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol. 1983;81:543-545.
11. Sacre RC, Fernandes NC, Vaisman M, et al. Melasma idiopático: avaliação das funcōes tireóidiana, prolactínica e gonadal feminina. An Bras Dermatol. 1996;71:195-198.
12. Hassan I, Kaur I, Sialy R, et al. Hormonal milieu in the maintenance of melasma in fertile women. J Dermatol. 1998;25:510-512.
13. Lufti RJ, Fridmanis M, Misrunas AL. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of melasma. J Clin Endocrinol Metab. 1985;61:28-31.
14. Smith AG, Shuster S, Thody AJ, et al. Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone. J Invest Dermatol. 1977;68:169-170.
15. Thody AJ, Plummer NA, Burton JL, et al. Plasma β-melanocyte- stimulating hormone levels in pregnancy. J Obstet Gynaecol Br Commonw. 1974;81:875-877.
16. Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228-237.
17. Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-733.
18. Johnston GA, Sviland L, McLelland J, et al. Melasma of the arms associated with hormone replacement therapy [letter]. Br J Dermatol. 1998;139:932.
19. Varma S, Roberts DL. Melasma of the arms associated with hormone replacement therapy [letter]. Br J Dermatol. 1999;141:592.
20. O'Brien TJ, Dyall-Smith D, Hall AP. Melasma of the arms associated with hormone replacement therapy [letter]. Br J Dermatol. 1999;141:592-593.
21. Kang WH, Chun SC, Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. J Dermatol. 1998;25:587-596.
22. Lee MH, Kim HJ, Ha DJ, et al. Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients. J Korean Med Sci. 2002;17:518-523.
23. Fulton JE Jr. Utilizing the ultraviolet (UV detect) camera to enhance the appearance of photodamage and other skin conditions. Dermatol Surg. 1997;23:163-169.
24. Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner's solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol. 1997;36:589-593.
25. Serup J, Agner T. Colorimetric quantification of erythema - a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin Exp Dermatol. 1990;15:267-272.
26. Huh CH, Seo KI, Park JY, et al. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology. 2003;206:316-320.
27. Ponzio HA, Cruz MF. Acurácia do exame sob lâmpada de Wood na ciassificação dos cloasmas. An Bras Dermatol. 1993;68:325-328.
28. Tabata H, Yamakage A, Yamazaki S. Bandlike melasma mimicking linear morphea ("en coup de sabre" type). Cutis. 1998;61:225-226.
29. Aloi F, Solaroli C, Giovannini E. Actinic lichen planus simulating melasma. Dermatology. 1997;195:69-70.
30. Gaddoni G, Baldassari L, Albertini F, et al. Melasma and acquired immunodeficiency syndrome (AIDS). J Eur Acad Dermatol Venereol. 1995;4:44-47.
31. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40-48.
32. Griffiths CE, Finkel LJ, Ditre CM, et al. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol. 1993;129:415-421.
33. Mishima Y. Histopathology of functional pigmentary disorders. Cutis. 1978;21:225-230.